001     291690
005     20250123112130.0
024 7 _ |a 10.18632/oncotarget.28527
|2 doi
024 7 _ |a pmid:39018218
|2 pmid
037 _ _ |a DKFZ-2024-01494
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Zhang, Yiyao
|0 P:(DE-HGF)0
|b 0
|e First author
245 _ _ |a Correction: Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer.
260 _ _ |a [Erscheinungsort nicht ermittelbar]
|c 2024
|b Impact Journals LLC
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1737627653_4292
|2 PUB:(DE-HGF)
|x Erratum/Correction
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a Original article: Oncotarget. 2015; 6:9999–10015. https://doi.org/10.18632/oncotarget.3171
536 _ _ |a 319H - Addenda (POF4-319H)
|0 G:(DE-HGF)POF4-319H
|c POF4-319H
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Gemcitabine
|2 NLM Chemicals
650 _ 7 |a Deoxycytidine
|0 0W860991D6
|2 NLM Chemicals
650 _ 7 |a Aspirin
|0 R16CO5Y76E
|2 NLM Chemicals
650 _ 7 |a Antimetabolites, Antineoplastic
|2 NLM Chemicals
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Gemcitabine
|2 MeSH
650 _ 2 |a Deoxycytidine: analogs & derivatives
|2 MeSH
650 _ 2 |a Deoxycytidine: pharmacology
|2 MeSH
650 _ 2 |a Deoxycytidine: therapeutic use
|2 MeSH
650 _ 2 |a Pancreatic Neoplasms: drug therapy
|2 MeSH
650 _ 2 |a Pancreatic Neoplasms: pathology
|2 MeSH
650 _ 2 |a Pancreatic Neoplasms: metabolism
|2 MeSH
650 _ 2 |a Drug Resistance, Neoplasm: drug effects
|2 MeSH
650 _ 2 |a Aspirin: pharmacology
|2 MeSH
650 _ 2 |a Aspirin: therapeutic use
|2 MeSH
650 _ 2 |a Neoplastic Stem Cells: drug effects
|2 MeSH
650 _ 2 |a Neoplastic Stem Cells: pathology
|2 MeSH
650 _ 2 |a Neoplastic Stem Cells: metabolism
|2 MeSH
650 _ 2 |a Antimetabolites, Antineoplastic: pharmacology
|2 MeSH
700 1 _ |a Liu, Lizhen
|0 P:(DE-He78)0144e4bf6eab6053de5a445069012063
|b 1
700 1 _ |a Fan, Pei
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Bauer, Nathalie
|0 P:(DE-He78)bf58bfc5eb550025e7f1f64520b68feb
|b 3
700 1 _ |a Gladkich, Jury
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Ryschich, Eduard
|b 5
700 1 _ |a Bazhin, Alexandr V
|b 6
700 1 _ |a Giese, Nathalia A
|b 7
700 1 _ |a Strobel, Oliver
|b 8
700 1 _ |a Hackert, Thilo
|b 9
700 1 _ |a Hinz, Ulf
|b 10
700 1 _ |a Gross, Matthias Wolfgang
|0 P:(DE-He78)d39b542b3a0da04c8892923daf9e5794
|b 11
700 1 _ |a Fortunato, Franco
|b 12
700 1 _ |a Herr, Ingrid
|0 P:(DE-HGF)0
|b 13
|e Last author
773 _ _ |a 10.18632/oncotarget.28527
|g Vol. 15, no. 1, p. 504 - 506
|0 PERI:(DE-600)2560162-3
|n 1
|p 504 - 506
|t OncoTarget
|v 15
|y 2024
|x 1949-2553
909 C O |p VDB
|o oai:inrepo02.dkfz.de:291690
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)0144e4bf6eab6053de5a445069012063
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)bf58bfc5eb550025e7f1f64520b68feb
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)d39b542b3a0da04c8892923daf9e5794
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-HGF)0
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-319H
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Addenda
|x 0
914 1 _ |y 2024
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-08-29
920 2 _ |0 I:(DE-He78)G403-20160331
|k G403
|l Molekulare Onkochirurgie
|x 0
920 1 _ |0 I:(DE-He78)G403-20160331
|k G403
|l Molekulare Onkochirurgie
|x 0
920 0 _ |0 I:(DE-He78)G403-20160331
|k G403
|l Molekulare Onkochirurgie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)G403-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21